28.10.2013
- Potential For Success - There is great promise for innovative R&D, generics and active pharmaceutical ingredient (API) manufacture in Russia and the countries that make up Central...
25.03.2013
- AstraZeneca has seen off a remaining threat to its top-selling cholesterol drug Crestor by settling a U.S. legal case with Watson Laboratories, a unit of Actavis, and Egis. The...
